<DOC>
	<DOC>NCT02955654</DOC>
	<brief_summary>The purpose of this study is to determine whether acceptance and commitment therapy is effective in the treatment of SSRIs-resistant obsessive- compulsive disorder.</brief_summary>
	<brief_title>Acceptance and Commitment Therapy in SSRI-Resistant Obsessive Compulsive Disorder</brief_title>
	<detailed_description>The patients who were SSRI-resistant will be randomized to ACT, aripiprazole, or SMT. Independent evaluators, blind to treatment,will evaluate patients during the study.The Yale-Brown Obsessive Compulsive Scale (YBOCS)will be used to measure OCD severity.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1. age between 18 and 65; 2. no less than 9 years in education; 3. a DSMIV diagnosis of OCD 4. moderately symptomatic (YaleBrown Obsessive Compulsive Scale score≥16) 5. received at least two kinds of SSRIs at optimal dose for more than 12 weeks An optimal dose is described as following: clomipramine hydrochloride, at least 225 mg/d;fluoxetine, at least 60 mg/d; paroxetine hydrochloride, at least 60 mg/d; sertraline hydrochloride, at least 200 mg/d; fluvoxamine, at least 250 mg/d; citalopram hydrobromide,at least 60 mg/d; and escitalopram oxalate, at least 40 mg/d.Patients who are unable to tolerate the supposed optimal doses were also eligible if at their maximally tolerated dose. 1. with comorbid Axis I psychiatric disorders 2. drug abuse in the last 3 months 3. HAMD&gt;25 4. too severe to receive ACT or evaluation 5. at high risk of suicide 6. pregnant or prepare for pregnancy 7. with somatic disorder 8. received aripiprazole(≥10mg for 8weeks) or ACT(8 times within 2 months) before 9. treated with no more than one kind of SSRI before</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>